JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Healthcare | 9.65% |
| 3 | Financials | 9.27% |
| 4 | Consumer Discretionary | 8.86% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4301
Lineage Cell Therapeutics
LCTX
$271M
| $792K | ﹤0.01% |
727,013
+17,535
| +2% | +$19.2K |
|
4302
NatWest
NWG
$75.9B
| $788K | ﹤0.01% |
139,888
+107,901
| +337% | +$573K |
|
|
YALA
4303
Yalla Group
YALA
$832M
| $785K | ﹤0.01% |
128,123
+82,479
| +181% | +$468K |
|
4304
Lufax Holding
LU
$1.3B
| $785K | ﹤0.01% |
255,739
-130,910
| -34% | -$488K |
|
|
CFLT
4305
CALL
DELISTED
Confluent
CFLT
| $782K | ﹤0.01% |
33,400
-3,100
| -8% | -$74.9K |
|
4306
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.37M
| $781K | ﹤0.01% |
+17,783
| New | +$760K |
|
4307
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
$3.7B
| $780K | ﹤0.01% |
+16,682
| New | +$738K |
|
4308
CALL
Datadog
DDOG
$91.7B
| $777K | ﹤0.01% |
6,400
+4,300
| +205% | +$443K |
|
4309
Summit Therapeutics
SMMT
$10.6B
| $773K | ﹤0.01% |
296,205
+82,391
| +39% | +$169K |
|
|
CNGL
4310
DELISTED
Canna-Global Acquisition Corp. Class A Common Stock
CNGL
| $773K | ﹤0.01% |
+71,037
| New | +$770K |
|
|
IGR
4311
CBRE Global Real Estate Income Fund
IGR
$715M
| $771K | ﹤0.01% |
141,975
+107,167
| +308% | +$491K |
|
|
OPRA
4312
Opera Ltd
OPRA
$1.82B
| $770K | ﹤0.01% |
58,214
+16,171
| +38% | +$191K |
|
4313
Miller Industries
MLR
$645M
| $770K | ﹤0.01% |
18,209
+10,597
| +139% | +$417K |
|
4314
Novavax
NVAX
$1.33B
| $769K | ﹤0.01% |
160,214
+25,687
| +19% | +$157K |
|
|
FFIC
4315
DELISTED
Flushing Financial
FFIC
| $768K | ﹤0.01% |
46,582
+20,857
| +81% | +$291K |
|
4316
Global X SuperDividend US ETF
DIV
$786M
| $766K | ﹤0.01% |
44,568
+9,796
| +28% | +$159K |
|
4317
NRC Health Common Stock
NRC
$469M
| $762K | ﹤0.01% |
19,260
+1,299
| +7% | +$54.4K |
|
4318
PUT
Affirm
AFRM
$26.2B
| $762K | ﹤0.01% |
+15,500
| New | +$448K |
|
4319
CALL
Performance Food Group
PFGC
$16.8B
| $761K | ﹤0.01% |
+11,000
| New | +$676K |
|
4320
State Street SPDR S&P Transportation ETF
XTN
$395M
| $759K | ﹤0.01% |
9,095
-701
| -7% | -$52.5K |
|
4321
Xeris Biopharma Holdings
XERS
$1.57B
| $758K | ﹤0.01% |
322,436
+205,480
| +176% | +$379K |
|
4322
CALL
ResMed
RMD
$32.4B
| $757K | ﹤0.01% |
4,400
| – | – |
|
|
FNA
4323
DELISTED
Paragon 28, Inc.
FNA
| $755K | ﹤0.01% |
60,761
+9,884
| +19% | +$105K |
|
4324
Magnachip Semiconductor
MX
$139M
| $751K | ﹤0.01% |
100,196
+50,346
| +101% | +$368K |
|
4325
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
| $750K | ﹤0.01% |
85,410
+71,273
| +504% | +$596K |
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $33.3B of net new capital in Q4 2023, opening 701 new positions and adding to 3,666 existing holdings. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $3.18B trimmed.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 619 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.